The delivery of siRNA and paclitaxel to glioma stem cells induced apoptosis, while increasing the differentiation of CD133+ glioma stem cells into non-stem cells improved the overall survival rate in mice bearing glioma tumours. The gene discussed is PROM1; the disease is glioma.